Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.82	3.62	2.4	2.86	7.48
Short-Term Investments	14.93	10.43	8.29	9.99	-
Cash & Short-Term Investments	18.75	14.06	10.69	12.85	7.48
Cash Growth	33.35%	31.44%	-16.79%	71.78%	2210.70%
Prepaid Expenses	1.26	0.87	0.59	0.52	0.72
Total Current Assets	20.01	14.93	11.29	13.37	8.2
Other Intangible Assets	0.38	0.48	0.58	0.7	0.81
Other Long-Term Assets	-	0.3	0.3	0.38	0.35
Total Assets	20.39	15.71	12.17	14.46	9.36
Accounts Payable	1.26	0.91	0.53	0.61	0.92
Accrued Expenses	3.68	2.68	2.45	2.32	2.43
Current Portion of Long-Term Debt	0.6	0.6	0.6	0.6	0.6
Other Current Liabilities	-	-	-	-	0.62
Total Current Liabilities	5.55	4.18	3.58	3.53	4.58
Long-Term Debt	1.72	2.32	2.92	3.52	4.12
Total Liabilities	7.27	6.5	6.51	7.05	8.7
Additional Paid-In Capital	84.09	64.37	51.87	47.86	31.66
Retained Earnings	-70.97	-55.17	-46.2	-37.52	-28.07
Treasury Stock	-	-	-	-2.93	-2.93
Comprehensive Income & Other	-0	-	-	-	-
Shareholders' Equity	13.12	9.2	5.66	7.41	0.66
Total Liabilities & Equity	20.39	15.71	12.17	14.46	9.36
Total Debt	2.32	2.92	3.52	4.12	4.72
Net Cash (Debt)	16.42	11.13	7.17	8.73	2.76
Net Cash Growth	47.50%	55.25%	-17.85%	216.41%	-
Net Cash Per Share	15.37	84.50	278.59	-	-
Filing Date Shares Outstanding	1.8	0.59	0.11	0.03	-
Total Common Shares Outstanding	1.5	0.26	0.03	0.01	-
Working Capital	14.46	10.75	7.7	9.84	3.62
Book Value Per Share	8.76	36.00	200.81	641.72	-
Tangible Book Value	12.74	8.72	5.08	6.7	-0.15
Tangible Book Value Per Share	8.50	34.11	180.13	580.68	-

Updated Mar 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q